Financiere de Tubize (CHIX:TUBB) Total Liabilities: €48.58 Mil (As of Dec. 2025)


CHIX:TUBB Financiere de Tubize SA CHIX:TUBB
44 GF Score
Price €235.20
! 2 Warning Signs
View Full Analysis

What is Financiere de Tubize Total Liabilities?

Financiere de Tubize CHIX:TUBB 44 Total Liabilities is €48.58 Mil as of Dec. 2025. GuruFocus rates CHIX:TUBB with a GF Score™ of 44/100. The stock has 2 warning signs investors should review.

Financiere de Tubize's Total Liabilities for the quarter that ended in Dec. 2025 was €48.58 Mil.

Financiere de Tubize's quarterly Total Liabilities declined from Dec. 2024 (€89.28 Mil) to Jun. 2025 (€0.37 Mil) but then increased from Jun. 2025 (€0.37 Mil) to Dec. 2025 (€48.58 Mil).

Financiere de Tubize's annual Total Liabilities declined from Dec. 2023 (€123.65 Mil) to Dec. 2024 (€89.28 Mil) and declined from Dec. 2024 (€89.28 Mil) to Dec. 2025 (€48.58 Mil).


Financiere de Tubize Total Liabilities Historical Data

* Premium members only.

The historical data trend for Financiere de Tubize's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Financiere de Tubize Total Liabilities Chart

Financiere de Tubize Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 54.42 87.19 123.65 89.28 48.58

Financiere de Tubize Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 123.65 31.69 89.28 0.37 48.58
CHIX:TUBB
44GF Score
Financiere de Tubize SA CHIX:TUBB
Total Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Financiere de Tubize Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Financiere de Tubize's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=1934.139-1885.56
=48.58

Financiere de Tubize's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=1934.139-1885.56
=48.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of €48.58 Mil mean?
Financiere de Tubize (CHIX:TUBB) has a Total Liabilities of €48.58 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Financiere de Tubize and its competitors.
Is Financiere de Tubize's Total Liabilities too high?
Financiere de Tubize's current Total Liabilities is €48.58 Mil. Overall, Financiere de Tubize has a GF Score™ of 44/100, reflecting its overall financial health beyond just this single metric.
How does Financiere de Tubize's Total Liabilities compare to VRTX and REGN?
Financiere de Tubize's Total Liabilities of €48.58 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Financiere de Tubize and its competitors. Financiere de Tubize's current Total Liabilities is €48.58 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Financiere de Tubize stock overvalued right now?
Financiere de Tubize (CHIX:TUBB) has a current Total Liabilities of €48.58 Mil. The current Total Liabilities is €48.58 Mil. Financiere de Tubize's overall GF Score™ is 44/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Financiere de Tubize (CHIX:TUBB), the current Total Liabilities is €48.58 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Financiere de Tubize Business Description

Address Allee de la Recherche, 60, Brussels, BEL, 1070
Financiere de Tubize SA is a holding company that owns a stake in UCB, a biopharmaceutical company. UCB is a world-wide biotechnology company that develops treatments for conditions related to neurology and immunology. UCB generates the vast majority of its revenue in the United States, followed by Europe and other international markets. Majority of its sales revenue is derived from its neurology products, followed by its immunology products. The company's plan focuses on leveraging scientific advances and skills in areas such as genetics, biomarkers, and human biology.
44GF Score

Get the complete analysis for CHIX:TUBB

Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€235.20
Price